# Bone remodeling markers: monitoring the changing bone

**Authors:** Nerea Varo

PMC · DOI: 10.1515/almed-2024-0009 · 2024-02-27

## Full-text entities

- **Genes:** BGLAP (bone gamma-carboxyglutamate protein) [NCBI Gene 632] {aka BGP, OC, OCN}, CYP27A1 (cytochrome P450 family 27 subfamily A member 1) [NCBI Gene 1593] {aka CP27, CTX, CYP27}, VDR (vitamin D receptor) [NCBI Gene 7421] {aka NR1I1, PPP1R163}
- **Diseases:** bone disease (MESH:D001847), osteoid formation (MESH:D058426), skeletal disease (MESH:D004194), diabetes (MESH:D003920), Fractures (MESH:D050723), osteoporotic fractures (MESH:D058866), bone frailty (MESH:D000073496), overweight (MESH:D050177), obesity (MESH:D009765), diabetes type 1 and 2 (MESH:D003924), Osteoporosis (MESH:D010024)
- **Chemicals:** pyridinoline (MESH:C015484), alendronate (MESH:D019386), EDTA (MESH:D004492), deoxypyridinoline (MESH:C036020), antiosteoporotic drugs (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC11019889